[
    "{\"step_by_step_thinking\": \"Yes, there are small molecule CGRPs under development for the treatment of migraine. Document [2] mentions that a number of small molecule antagonists of the CGRP receptor have been developed for migraine therapy, and the majority of the clinical trials conducted have proven positive. Document [31] also states that atogepant and rimegepant, which are small molecule CGRP receptor antagonists, have been evaluated in clinical trials for the preventive treatment of migraine and have shown efficacy and safety. Therefore, the answer is A. yes.\", \"answer_choice\": \"A\"}"
]